Ioannis Tsamesidis
Overview
Explore the profile of Ioannis Tsamesidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pouroutzidou G, Papadopoulou L, Lazaridou M, Tsachouridis K, Papoulia C, Patsiaoura D, et al.
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986685
Silica-based ceramics doped with calcium and magnesium have been proposed as suitable materials for scaffold fabrication. Akermanite (CaMgSiO) has attracted interest for bone regeneration due to its controllable biodegradation rate,...
12.
Tsamesidis I, Theocharidou A, Beketova A, Bousnaki M, Chatzimentor I, Pouroutzidou G, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839977
A promising strategy to enhance bone regeneration is the use of bioactive materials doped with metallic ions with therapeutic effects and their combination with active substances and/or drugs. The aim...
13.
Nakiou E, Lazaridou M, Pouroutzidou G, Michopoulou A, Tsamesidis I, Liverani L, et al.
Polymers (Basel)
. 2022 Nov;
14(22).
PMID: 36433155
Background: Aliphatic polyesters are widely used for biomedical, pharmaceutical and environmental applications due to their high biodegradability and cost-effective production. Recently, star and hyperbranched polyesters based on glycerol and ω-carboxy...
14.
Kotzaeroglou A, Tsamesidis I
Medicines (Basel)
. 2022 Nov;
9(11).
PMID: 36422118
Increasing evidence suggests that the presence of oxidative stress and disorders of the antioxidant defense system are involved in a wide range of neuropsychiatric disorders, such as bipolar disorder, schizophrenia...
15.
Lymperaki E, Kazeli K, Tsamesidis I, Nikza P, Poimenidou I, Vagdatli E
Clin Pract
. 2022 Aug;
12(4):599-608.
PMID: 36005066
During the last couple of critical years, worldwide, there have been more than 550 million confirmed cases of COVID-19, including more than 6 million deaths (reported by the WHO); with...
16.
Lymperaki E, Kazeli K, Variti G, Gerothanasi M, Gkinoudis A, Tsamesidis I, et al.
Medicines (Basel)
. 2022 Jun;
9(6).
PMID: 35736249
COVID-19 disease is still a major global concern because of its morbidity and its mortality in severe disease. Certain biomarkers including Reactive Oxygen Species (ROS), vitamins, and trace elements are...
17.
Lymperaki E, Stalika E, Tzavelas G, Tormpantoni E, Samara D, Vagdatli E, et al.
Clin Pract
. 2022 Jun;
12(3):406-418.
PMID: 35735664
Objective: The objective of this study is to further highlight the differences between different ABO blood groups and Rhesus types with health biomarkers. Methods: In total 150 active healthy blood...
18.
Karagianni K, Pettas S, Kanata E, Lioulia E, Thune K, Schmitz M, et al.
Antioxidants (Basel)
. 2022 Apr;
11(4).
PMID: 35453411
Prion diseases are transmissible encephalopathies associated with the conversion of the physiological form of the prion protein (PrP) to the disease-associated (PrP). Despite intense research, no therapeutic or prophylactic agent...
19.
Pouroutzidou G, Lazaridou M, Papoulia C, Tsamesidis I, Chrissafis K, Vourlias G, et al.
Nanomaterials (Basel)
. 2022 Mar;
12(5).
PMID: 35269337
Engineered electrospun membranes have emerged as promising materials in guided tissue regeneration, as they provide an appropriate framework for the formation of new functional periodontal tissues. The development of multifunctional...
20.
Gkiliopoulos D, Tsamesidis I, Theocharidou A, Pouroutzidou G, Christodoulou E, Stalika E, et al.
Nanomaterials (Basel)
. 2022 Mar;
12(5).
PMID: 35269309
(1) Background: A proposed approach to promote periodontal tissue regeneration in cases of peri-implantitis is the local administration of growth factors at the implant site. Recombinant human bone morphogenetic protein-2...